| Issue |
Title |
File |
| Vol 14, No 7 (2014) |
Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents |
(Eng)
|
|
Akiyama M., Izumi H., Wang K., Yamaguchi T., Kuma A., Kitamura N., Harada Y., Oya R., Yamaguchi K., Iwai Y., Kohno K.
|
| Vol 11, No 9 (2011) |
Hypoxia-Inducible Factors and Sphingosine 1-Phosphate Signaling |
(Eng)
|
|
Cuvillier O., Ader I.
|
| Vol 15, No 3 (2015) |
Identification and Characterization of the Biosynthetic Gene Cluster of Thiolutin, a Tumor Angiogenesis Inhibitor, in Saccharothrix algeriensis NRRL B-24137 |
(Eng)
|
|
Huang S., Tong M., Qin Z., Deng Z., Deng H., Yu Y.
|
| Vol 25, No 17 (2025) |
Identification of Flavonoid-based Hypoxia-inducible Factor-2 Alpha Inhibitors for the Treatment of Breast Cancer– In silico and In vitro Evidence |
(Eng)
|
|
Shahinaz ., Baba M., Gor R., Ramamurthy C., Mohideen H., Ramalingam S., Vijayakumar T.
|
| Vol 24, No 4 (2024) |
Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction |
(Eng)
|
|
Krishnan K. A., George Valavi S., Joy A.
|
| Vol 23, No 9 (2023) |
Imidazole and Biphenyl Derivatives as Anti-cancer Agents for Glioma Therapeutics: Computational Drug Repurposing Strategy |
(Eng)
|
|
Murali P., Karuppasamy R.
|
| Vol 15, No 3 (2015) |
Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’? |
(Eng)
|
|
Pilotto S., Kinspergher S., Peretti U., Calio A., Carbognin L., Ferrara R., Brunelli M., Chilosi M., Tortora G., Bria E.
|
| Vol 15, No 10 (2015) |
Immunogenicity, Immunopathogenicity, and Immunotolerance in One Graph |
(Eng)
|
|
Kanduc D.
|
| Vol 24, No 19 (2024) |
Immunologic Mechanisms of BCc1 Nanomedicine Synthesized by Nanochelating Technology in Breast Tumor-bearing Mice: Immunomodulation and Tumor Suppression |
(Eng)
|
|
Karimi P., Fakharzadeh S., Kalanaky S., Hafizi M., Hashemi M., Mahdavi M., Nazaran M.
|
| Vol 12, No 8 (2012) |
Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents |
(Eng)
|
|
Ghiringhelli F., Rebe C., Hichami A., Delmas D.
|
| Vol 24, No 20 (2024) |
Immunomodulatory Roles of IL-15 in Immune Cells and its Potential for Cancer Immunotherapy |
(Eng)
|
|
Liu Y., Ma W., Tian X., Wang Q., Lu X., Luo Y., Xu J.
|
| Vol 15, No 9 (2015) |
Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer |
(Eng)
|
|
Zhang C., Ben A., Reville J., Calabrese V., Villa N., Bandyopadhyay M., Dasgupta S.
|
| Vol 10, No 6 (2010) |
Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells |
(Eng)
|
|
M. Hofman F., Stathopoulos A., A. Kruse C., C. Chen T., E.J.C. Schijns V.
|
| Vol 23, No 19 (2023) |
Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells |
(Eng)
|
|
Erdem İ.
|
| Vol 12, No 1 (2012) |
Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer |
(Eng)
|
|
Hardy S., G. Julien S., L. Tremblay M.
|
| Vol 14, No 1 (2014) |
Implication of CYP24A1 Splicing in Breast Cancer |
(Eng)
|
|
Scheible C., Thill M., Baum S., Solomayer E., Friedrich M.
|
| Vol 14, No 1 (2014) |
Implication of CYP24A1 Splicing in Breast Cancer |
(Eng)
|
|
Scheible C., Thill M., Baum S., Solomayer E., Friedrich M.
|
| Vol 24, No 13 (2024) |
Improving Tamoxifen Performance in Inducing Apoptosis and Hepatoprotection by Loading on a Dual Nanomagnetic Targeting System |
(Eng)
|
|
Zhao Y., Ding W., Zhang P., Deng L., Long Y., Lu J., Shiri F., Heidari Majd M.
|
| Vol 14, No 10 (2014) |
Improving the Efficacy of Plant Polyphenols |
(Eng)
|
|
Biasutto L., Mattarei A., Sassi N., Azzolini M., Romio M., Paradisi C., Zoratti M.
|
| Vol 15, No 1 (2015) |
In Search of Natural Remediation for Cervical Cancer |
(Eng)
|
|
Roy M., Mukherjee A., Sarkar R., Mukherjee S., Biswas J.
|
| Vol 23, No 19 (2023) |
In silico Screening and Validation of Achyranthes aspera as a Potential Inhibitor of BRAF and NRAS in Controlling Thyroid Cancer |
(Eng)
|
|
Alamri A., Alkhilaiwi F., Khan N., Tasleem M.
|
| Vol 13, No 10 (2013) |
In Silico Study of Desmosdumotin as an Anticancer Agent: Homology Modeling, Docking and Molecular Dynamics Simulation Approach |
(Eng)
|
|
Gadhe C., Kothandan G., Cho S.
|
| Vol 23, No 9 (2023) |
In silico Study on the Binding Interactions of SSTA and 18F-SSTA Towards Somatostatin Receptor Subtype 2 |
(Eng)
|
|
Pérez D., Razo-Hernández R., Ávila-Rodríguez M.
|
| Vol 25, No 3 (2025) |
In silico-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers |
(Eng)
|
|
Cordova-Bahena L., Landero-Marin C., Flores-Hernandez X., Alvarez-Coronel L., Jimenez-Uribe A., Salinas-Jazmin N., An Z., Velasco-Velazquez M.
|
| Vol 25, No 15 (2025) |
In vitro and In vivo Growth Inhibition and Apoptosis of Cancer Cells by Ethyl 4-[(4-methylbenzyl)oxy] Benzoate Complex |
(Eng)
|
|
Auwal A., Al Banna M.H., Pronoy T., Hossain M.M., Rashel K., Kabir S.R., Ansary M.R., Islam F.
|
| Vol 16, No 12 (2016) |
In Vitro Anticancer Effects of Two New Potent Hydrazide Compounds on Leukemic Cells |
(Eng)
|
|
Tavakolfar S., Mousavi E., Almasirad A., Amanzadeh A., Atyabi S., Yaghamii P., Samiee-Sadr S., Salimi M.
|
| Vol 12, No 8 (2012) |
In Vitro Synergistic Interaction between DTA0100 and Radiation in Human Cancer Cell Lines |
(Eng)
|
|
Bordon E., G. Leon L., Rios-Luci C., C. Lara P., M. Padron J.
|
| Vol 15, No 6 (2015) |
In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH2Ph)]Br |
(Eng)
|
|
Garcia-Moreno E., Gascon S., Garcia de Jalon J., Romanos E., Rodriguez-Yoldi M., Cerrada E., Laguna M.
|
| Vol 15, No 7 (2015) |
In Vivo Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice |
(Eng)
|
|
Akhtar M., Zulfadli A., Kee B., Abdullah M., Omar A., Alitheen N., Abu N., Mohamed N., Yeap S., Lim K.
|
| Vol 25, No 7 (2025) |
In vivo, In vitro, and In silico Studies of Umbelliferone and Irinotecan on MDA-MB-231 Breast Cancer Cell Line and Drosophila melanogaster Larvae |
(Eng)
|
|
Tamturk E., Yalcın S., Ercan F., Tuncbilek A.
|
| Vol 16, No 12 (2016) |
In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by Its Active Flavonoids in Breast Cancer Cells |
(Eng)
|
|
Noolu B., Gogulothu R., Bhat M., Qadri S., Reddy V., Reddy G., Ismail A.
|
| Vol 24, No 9 (2024) |
Indirubin, an Active Component of Indigo Naturalis, Exhibits Inhibitory Effects on Leukemia Cells via Targeting HSP90AA1 and PI3K/Akt Pathway |
(Eng)
|
|
Yao Y., Li X., Yang X., Mou H., Wei L.
|
| Vol 16, No 2 (2016) |
Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review |
(Eng)
|
|
Sidhu J., Singla R., Mayank ., Jaitak V.
|
| Vol 11, No 1 (2011) |
In-Gel Protein Phosphatase Assays and Other Useful Methods for the Detection of Protein Phosphatase Activities |
(Eng)
|
|
Ishida A., Kameshita I.
|
| Vol 12, No 7 (2012) |
Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment |
(Eng)
|
|
Stellas D., Patsavoudi E.
|
| Vol 13, No 4 (2013) |
Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo |
(Eng)
|
|
A. Ucar D., T. Magis A., He D., J. Lawrence N., M. Sebti S., Kurenova E., Zajac-Kaye M., Zhang J., N. Hochwald S.
|
| Vol 13, No 7 (2013) |
Inhibition of Akt/mTOR Signaling by the Dietary Flavonoid Fisetin |
(Eng)
|
|
Syed D., Adhami V., Khan M., Mukhtar H.
|
| Vol 11, No 7 (2011) |
Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis |
(Eng)
|
|
P. Teng B., D. Heffler M., C. Lai E., Zhao Y., M. LeVea C., M. Golubovskaya V., M. BullardDunn K.
|
| Vol 13, No 7 (2013) |
Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention |
(Eng)
|
|
Bruning A.
|
| Vol 13, No 5 (2013) |
Inhibition of PCAF by Anacardic Acid Derivative Leads to Apoptosis and Breaks Resistance to DNA Damage in BCR-ABL-expressing Cells |
(Eng)
|
|
Kobialka M.K., Ruszkowska W.D., Ghizzoni M., Dekker F.J., Piwocka K.
|
| Vol 23, No 17 (2023) |
Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells |
(Eng)
|
|
Serttas R., Erdogan S.
|
| Vol 15, No 7 (2015) |
Inhibition of Testosterone Aromatization by the Indole-3-carbinol Derivative CTet in CYP19A1-overexpressing MCF-7 Breast Cancer Cells |
(Eng)
|
|
Santi M., Carloni E., Galluzzi L., Diotallevi A., Lucarini S., Magnani M., Brandi G.
|
| Vol 16, No 10 (2016) |
Inhibitors of Cancer Stem Cells |
(Eng)
|
|
García-Rubiño M., Lozano-López C., Campos J.
|
| Vol 25, No 13 (2025) |
In-silico and In-vitro Molecular Analysis of Oleanolic Acid and Cisplatin on Pancreatic Cancer (Panc-1 Cell Line) |
(Eng)
|
|
Devi Jegannathan S., Jayapal W., Jayaprakash B., Prabhu T.
|
| Vol 23, No 12 (2023) |
In-silico Evaluation of Novel Honokiol Derivatives against Breast Cancer Target Protein LKB1 |
(Eng)
|
|
Shahid I., Shoaib M., Raza R., Jahangir M., Abbasi S., Riasat A., Akbar A., Mehnaz S.
|
| Vol 11, No 5 (2011) |
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer |
(Eng)
|
|
Rieder S., W. Michalski C., Friess H., Kleeff >.
|
| Vol 13, No 6 (2013) |
Integrated Therapeutic Approaches in Head and Neck Cancer: The Importance of Multidisciplinary Team Management |
(Eng)
|
|
Perri F., Muto P., Aversa C., Daponte A., Vittoria G., Pepe S., Caponigro F.
|
| Vol 13, No 6 (2013) |
Integrated Therapeutic Approaches in the Treatment of Locally Advanced Non-small Cell Lung Cancer |
(Eng)
|
|
Maio M., Costanzo R., Giordano P., Piccirillo M., Sandomenico C., Montanino A., Carillio G., Muto P., Jones D., Daniele G., Perrone F., Rocco G., Morabito A.
|
| Vol 23, No 18 (2023) |
Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy |
(Eng)
|
|
Shiri Aghbash P., Rasizadeh R., Yari A., Lahouti S., MotieGhader H., Nahand J., Entezari-Maleki T., Baghi H.
|
| Vol 23, No 17 (2023) |
Intermittent Fasting against Cancer Development and Progression: Highlighting Potential Anticancer Molecular Mechanisms |
(Eng)
|
|
Psara E., Poulios E., Papadopoulou S., Tolia M., Vasios G., Giaginis C.
|
| Vol 14, No 10 (2014) |
Intracellular Distribution and Biological Effects of Phytochemicals in a Sex Steroid- Sensitive Model of Human Prostate Adenocarcinoma |
(Eng)
|
|
Smeriglio A., Trombetta D., Marcoccia D., Narciso L., Mantovani A., Lorenzetti S.
|
| Vol 14, No 1 (2014) |
Intracellular Expression of Inflammatory Proteins S100A8 and S100A9 Leads to Epithelial-mesenchymal Transition and Attenuated Aggressivity of Breast Cancer Cells |
(Eng)
|
|
Cormier K., Harquail J., Ouellette R., Tessier P., Guerrette R., Robichaud G.
|
| Vol 14, No 1 (2014) |
Intracellular Expression of Inflammatory Proteins S100A8 and S100A9 Leads to Epithelial-mesenchymal Transition and Attenuated Aggressivity of Breast Cancer Cells |
(Eng)
|
|
Ouellette R., Tessier P., Guerrette R., Robichaud G., Cormier K., Harquail J.
|
| Vol 15, No 9 (2015) |
Intracellular ROS Generation Mediates Maleimide-induced Cytotoxicity in Leukemia Cells |
(Eng)
|
|
Rosolen D., Noldin V., Winter E., Filippin-Monteiro F., Campos-Buzzi F., Cechinel-Filho V., Creczynski-Pasa T.
|
| Vol 12, No 7 (2012) |
Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream |
(Eng)
|
|
Okazaki I., Nabeshima K.
|
| Vol 23, No 15 (2023) |
Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells |
(Eng)
|
|
Maleki F., Sadeghian H., Bahrami A., Goftari S., Matin M.
|
| Vol 24, No 10 (2024) |
Investigating the Effects of Dorema hyrcanum Root Extracts on Selective Induction of Programmed Cell Death in Glioblastoma, Ovarian Cancer and Breast Cancer Cell Lines |
(Eng)
|
|
Shandi M., Sahranavard S., Bagheri F., Shahsavari Z., Salami S.
|
| Vol 16, No 10 (2016) |
Investigation of Fucoidan-Oleic Acid Conjugate for Delivery of Curcumin and Paclitaxel |
(Eng)
|
|
Phan U., Nguyen K., Vo T., Duan W., Tran P., Tran T.
|
| Vol 25, No 10 (2025) |
Investigation of the Anticarcinogenic Effects of Hypericum perforatum Extract on Human Thyroid Cancer |
(Eng)
|
|
Gokcek-Sarac C., Altunkaya G., Karakurt S.
|
| Vol 24, No 13 (2024) |
Ionic Liquids Immobilized Synthesis of New Xanthenes Derivatives and their Antiproliferative, Molecular Docking, and Morphological Studies |
(Eng)
|
|
Mohareb R., Ibrahim R., Al Farouk F., Alwan E.
|
| Vol 25, No 9 (2025) |
Irisquinone's Anti-cancer Potential: Targeting TrxR to Trigger ROS-mediated Apoptosis and Pyroptosis |
(Eng)
|
|
Zhang Q., Wang X., Tana G., Liang G., Ma Y., Bu R., Ga L.
|
| Vol 13, No 9 (2013) |
Is Effective and Safe a Radiochemotherapy Approach in Elderly Cancer Patients? A Review |
(Eng)
|
|
Fiorica F., Zanghì A., Pascale G., Nuta O., Pup L., Stefanelli A., Cartei F.
|
| Vol 15, No 7 (2015) |
Is Notch Signaling a Specific Target in Hepatocellular Carcinoma? |
(Eng)
|
|
Sun L., Sun G., Yu Y., H. Coy D.
|
| Vol 24, No 17 (2024) |
Isolation and Characterization of Cytotoxic Compounds from Detarium microcarpum Guill. and Perr. Stem Bark |
(Eng)
|
|
Salawu K., Ogbole O., Abiodun O., Wang Y.
|
| Vol 23, No 12 (2023) |
Isolinderalactone Resistance to the Liver Injury Induced by Oxaliplatin in Rats Through Inhibiting IL-6/STAT3 Signal Pathway |
(Eng)
|
|
Lin R., Zhou Y., Hu C., Yao H., Jin W.
|
| Vol 15, No 3 (2015) |
Isothiouronium Salts Reduce NRAS Expression, Induce Apoptosis and Decrease Invasion of Melanoma Cells |
(Eng)
|
|
Cisilotto J., Ferreira M., Filippin-Monteiro F., Bortoluzzi A., Sa M., Creczynski-Pasa T.
|
| Vol 24, No 5 (2024) |
Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage |
(Eng)
|
|
Fan N., Zhang L., Wang Z., Ding H., Yue Z.
|
| Vol 12, No 9 (2012) |
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation? |
(Eng)
|
|
P. S. Santos F., Verstovsek S.
|
| Vol 23, No 11 (2023) |
JDHY3 Inhibits Hypopharyngeal Carcinoma Cell Proliferation and Promotes Apoptosis by Inhibiting the PI3K/AKT Pathway |
(Eng)
|
|
Dai W., Ni Z., Zhang G., Xu J., Qin X., Cao J., Liu L.
|
| Vol 24, No 6 (2024) |
JHD205, A Novel Abemaciclib Derivative, Exerts Antitumor Effects on Breast Cancer by CDK4/6 |
(Eng)
|
|
Ji J., Qin J., Wang X., Lv M., Hou X., Jing A., Zhou J., Zuo L., Liu W., Feng J., Qian Q., Liu Y., Wang X., Liu B.
|
| Vol 24, No 5 (2024) |
Karanjin, A Promising Bioactive Compound Possessing Anti-cancer Activity against Experimental Model of Non-small Cell Lung Cancer Cells |
(Eng)
|
|
Kumar G., Pandey D.M., Ghosh M., Dall'Acqua S., Gupta R., Tiwari N., Mohd Siddique U., Vishwakrama L., Guleri S.K., Lal U., Dubey S.
|
| Vol 23, No 19 (2023) |
Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway |
(Eng)
|
|
Jiang J., Zhang C., Wang J., Zhu Y., Wang X., Mao P.
|
| Vol 23, No 15 (2023) |
KRAS Mutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and Apoptosis |
(Eng)
|
|
Betul Yenigun V., Acar H., Kanimdan E., Yenigun A., Kocyigit A., Cora T.
|
| Vol 25, No 2 (2025) |
Lapatinib: A Potential Therapeutic Agent for Colon Cancer Targeting Ferroptosis |
(Eng)
|
|
Sun Y., Wang D., Yuan C., Lang X., Fu S.
|
| Vol 10, No 4 (2010) |
Latest Insights into the Anticancer Activity of Gold(III)-Dithiocarbamato Complexes |
(Eng)
|
|
Ronconi L., Aldinucci D., Ping Dou Q., Fregona D.
|
| Vol 23, No 12 (2023) |
LCMS Determination and Cytotoxicity of Abrus precatorius on L6 and SK-N-MC Cell Lines |
(Eng)
|
|
Naduchamy K., Parthasarathy V.
|
| Vol 11, No 3 (2011) |
Lenalidomide Current Understanding of Mechanistic Properties |
(Eng)
|
|
Tageja N.
|
| Vol 16, No 11 (2016) |
Lenalidomide in an in vitro Dendritic Cell Model for Malignant Gliomas |
(Eng)
|
|
Kühnöl C., Staege M., Kramm C.
|
| Vol 15, No 5 (2015) |
Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics |
(Eng)
|
|
Arkwright R., Deshmukh R., Adapa N., Stevens R., Zonder E., Zhang Z., Farshi P., Ahmed R., El-Banna H., Chan T., Dou Q.
|
| Vol 15, No 6 (2015) |
Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways |
(Eng)
|
|
Han J., Song J., Li X., Zhu M., Guo W., Xing W., Zhao R., He X., Liu X., Wang S., Li Y., Huang H., Xu X.
|
| Vol 14, No 4 (2014) |
Lipid Rafts, Endoplasmic Reticulum and Mitochondria in the Antitumor Action of the Alkylphospholipid Analog Edelfosine |
(Eng)
|
|
Gajate C., Mollinedo F.
|
| Vol 24, No 12 (2024) |
Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses |
(Eng)
|
|
Yazdan M., Naghib S.M., Mozafari M.R.
|
| Vol 15, No 2 (2015) |
Liposome Encapsulated All Trans Retinoic Acid (ATRA) has Enhanced Immunomodulatory and Inflammation Reducing Activities in Mice Model |
(Eng)
|
|
Berlin Grace V., Siddikuzzaman ., Rimashree B.
|
| Vol 10, No 2 (2010) |
Liver Cancer Stem Cells as an Important Target in Liver Cancer Therapies |
(Eng)
|
|
Zou G.
|
| Vol 15, No 4 (2015) |
Low Concentration of Caffeine Inhibits the Progression of the Hepatocellular Carcinoma via Akt Signaling Pathway |
(Eng)
|
|
Dong S., Kong J., Kong J., Shen Q., Kong F., Sun W., Zheng L.
|
| Vol 10, No 2 (2010) |
Lung Cancer Stem Cells as a Target for Therapy |
(Eng)
|
|
Gorelik E., Lokshin A., Levina V.
|
| Vol 24, No 20 (2024) |
Lupiwighteone as an Antitumor Agent Reverses Multidrug Resistance in K562/ADR Cells by Regulating Cellular Prion Protein-Oct4 Axis |
(Eng)
|
|
Hu K., Zhang J., Zhang Y., Wu X., Jin X., Mao S., Ding P., Wu S., Ren J.
|
| Vol 16, No 10 (2016) |
Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents |
(Eng)
|
|
Küçükgüzel Ş., Coşkun G.
|
| Vol 23, No 19 (2023) |
Male Breast Cancer: Three Case Reports and a Literature Review |
(Eng)
|
|
Xin Y., Wang F., Ren D., Zhao F., Zhao J.
|
| Vol 10, No 1 (2010) |
Male Fertility-Implications of Anticancer Treatment and Strategies to Mitigate Gonadotoxicity |
(Eng)
|
|
Ragheb A., Sabanegh Jr. E.
|
| Vol 13, No 9 (2013) |
Management Of Elderly Patients With Diffuse Large B-Cell Lymphomas |
(Eng)
|
|
Ciancia R., Tirelli U., Ribera J., Spina M.
|
| Vol 23, No 16 (2023) |
Managing Cancer Treatment in Patients with Renal Dysfunction: The Role of Chemotherapy |
(Eng)
|
|
Aghsaeifard Z., Alizadeh R.
|
| Vol 11, No 2 (2011) |
Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis |
(Eng)
|
|
Hempel N., M. Carrico P., Melendez J.A.
|
| Vol 13, No 4 (2013) |
Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status |
(Eng)
|
|
Petit K., Biard J.
|
| Vol 15, No 3 (2015) |
Marizomib, A Potent Second Generation Proteasome Inhibitor from Natural Origin |
(Eng)
|
|
Ma L., Diao A.
|
| Vol 24, No 1 (2024) |
Matrix Metalloproteinases in Oral Cancer Pathogenesis and their Use in Therapy |
(Eng)
|
|
Maurya S., Prasad D., Mukherjee S.
|
| Vol 23, No 16 (2023) |
MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53 |
(Eng)
|
|
Wang Y., Yin J., Shi X., Zhao X., Li B., Yang M.
|
| Vol 23, No 16 (2023) |
Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking |
(Eng)
|
|
Li H., Jing Y., Chai Y., Sun X., He X., Xue S., Xi Y., Ma X.
|
| Vol 23, No 9 (2023) |
Mechanisms of Cancer-killing by Quercetin; A Review on Cell Death Mechanisms |
(Eng)
|
|
Wang H., Dong Z., Liu J., Zhu Z., Najafi M.
|
| Vol 10, No 4 (2010) |
Mechanisms of Cytotoxicity of Anticancer Titanocenes |
(Eng)
|
|
Olszewski U., Hamilton G.
|
| 601 - 700 of 1242 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
